Ensuring Biosafety in Next-Generation Immunotherapies: Strategies and Challenges
17 Jun 2025
Clinical Development
- Best practices for biosafety assessment in immunotherapies.
- Regulatory considerations for biosafety in immunotherapeutic product development.
- Risk mitigation strategies during manufacturing and clinical application.
